154 related articles for article (PubMed ID: 12080274)
1. Yasmin--an oral contraceptive with a new progestin.
Med Lett Drugs Ther; 2002 Jun; 44(1133):55-7. PubMed ID: 12080274
[No Abstract] [Full Text] [Related]
2. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
3. Is [symbol: see text] Yasmin a "truly different" pill?
Drug Ther Bull; 2002 Aug; 40(8):57-9. PubMed ID: 12216337
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of a new oral contraceptive containing drospirenone.
Shulman LP
J Reprod Med; 2002 Nov; 47(11 Suppl):981-4. PubMed ID: 12497672
[TBL] [Abstract][Full Text] [Related]
5. Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Dickerson V
J Reprod Med; 2002 Nov; 47(11 Suppl):985-93. PubMed ID: 12497673
[TBL] [Abstract][Full Text] [Related]
6. Yasmin: the reason why.
Thorneycroft IH
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():13-8; discussion 42-3. PubMed ID: 12659402
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolism associated with the new contraceptive Yasmin.
van Grootheest K; Vrieling T
BMJ; 2003 Feb; 326(7383):257. PubMed ID: 12560278
[No Abstract] [Full Text] [Related]
8. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
Dunn N
BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
[No Abstract] [Full Text] [Related]
9. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.
Oelkers W
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():19-26; discussion 42-3. PubMed ID: 12659403
[TBL] [Abstract][Full Text] [Related]
10. The truth about oral contraceptives and venous thromboembolism.
Shulman LP; Goldzieher JW
J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
[TBL] [Abstract][Full Text] [Related]
11. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E
Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161
[No Abstract] [Full Text] [Related]
12. Transient ischaemic attack associated with the new contraceptive Yasmin.
Vayá A; Mira Y; Ferrando F; Aznar J; García-Fuster MJ
Thromb Res; 2003; 112(1-2):121. PubMed ID: 15013284
[No Abstract] [Full Text] [Related]
13. Deep vein thrombosis associated with the new oral contraceptive Yasmin.
Oo TH
South Med J; 2009 Sep; 102(9):985-6. PubMed ID: 19668042
[No Abstract] [Full Text] [Related]
14. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism after high-dose chemotherapy in a patient with Hodgkin's lymphoma receiving the new oral contraceptive ethinylestradiol and drospirenone ("Yasmine").
Tartarone A; Gallucci G; Cammarota A; Romano G; Ardito R; Di Renzo N
Bone Marrow Transplant; 2005 Jan; 35(1):103. PubMed ID: 15531905
[No Abstract] [Full Text] [Related]
16. YAZ and the novel progestin drospirenone.
Mishell DR
J Reprod Med; 2008 Sep; 53(9 Suppl):721-8. PubMed ID: 18980044
[TBL] [Abstract][Full Text] [Related]
17. Psychosexual well-being in women using oral contraceptives containing drospirenone.
Nappi RE; Albani F; Tonani S; Santamaria V; Pisani C; Terreno E; Martini E; Polatti F
Funct Neurol; 2009; 24(2):71-5. PubMed ID: 19775533
[TBL] [Abstract][Full Text] [Related]
18. Is Yasmin as safe as other contraceptive pills?
Mira Y; Morata C; Vayá A; Ferrando F; Contreras T; Aznar J
Clin Appl Thromb Hemost; 2006 Jul; 12(3):378-9. PubMed ID: 16959696
[No Abstract] [Full Text] [Related]
19. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.
Dinger JC; Heinemann LA; Kühl-Habich D
Contraception; 2007 May; 75(5):344-54. PubMed ID: 17434015
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives.
Med Lett Drugs Ther; 2000 May; 42(1078):42-4. PubMed ID: 10847115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
